Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based CEO’ operating in the Medical space. If you think a CEO’ is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Varsha Rao
Chief Executive Officer of Nurx
Varsha Rao is the CEO of Nurx, which is revolutionizing healthcare by home-delivering prescriptions, medication, and screening tests. She is a Board Member at ViaSat Inc., and the former COO of Clover Health, a health insurance startup developing an innovative platform that collects and analyzes long-term medical data to improve the health management and wellbeing of its clients. Varsha previously served as Head of Global Operations at Airbnb, where she was responsible for managing 16 offices across the globe and leading the company’s customer service and trust and safety teams in Oregon, Portland, Singapore, Dublin and San Francisco. Under her leadership, the company’s operations in Asia expanded, with many new hosts and visitors joining the Airbnb family. However, her entrepreneurial journey began much earlier, in 1998 when she founded Eve.com together with Mariam Naficy. Eve.com quickly became the leading e-commerce retailer for beauty and accessories. Within two years the company grew to 125 employees. Eve.com was sold to Idealab in early 2000 for $110M. In 1999, Fortune Magazine named the company as the 6th Best e-commerce site. Between founding Eve.com and landing at Airbnb, Rao has held a variety of senior roles. She was appointed VP, Category Marketing at Keen/Ingenio (acquired by AT&T) in 2001 and managed P&L for new and emerging major categories. In 2004-2008, she was VP, General Manager for OldNavy.com, the online division of Gap, Inc., where she led the company’s product development, marketing and merchandising efforts, resulting in a 60% increase in revenues. Rao went on to join SingTel as CEO, Digital Media in 2008 and led the team to launch its local search & reviews business inSing.com. After 3 years at SingTel she left to become Senior Vice President, International for LivingSocial where she was the first LivingSocial employee in Asia. As Senior VP, Rao managed more than 2,000 employees in the company’s network of offices in Asia, Australia, New Zealand, Latin America and Europe. Varsha is a Sequoia Capital Scout, and a mentor for the KStart Catalyst, an incubator and seed investment program for early stage startups in India. She herself has also invested in several startups in various fields including e-commerce, finance and renewable energy. In 2014, she was named by San Francisco Business Times as one of the ‘Most Influential Business Women’ in the Bay Area and in 2016 she featured in The Boardlist’s top 20 list of women every Silicon Valley tech company should be adding to their board. Rao received her BS/BA in Economics/Math from the University of Pennsylvania. For two years following graduation, she worked at the Wasserstein Perella financial consulting firm, where she advised clients on private and public investment strategies. She then returned to school to obtain an MBA from Harvard Business School. As a strong believer in the power of education she contributes to a variety of educational initiatives for underprivileged children and youth. Among them Breakthrough, a program that works to motivate and empower K12 students to continue to higher education and excel academically and professionally.
Follow Varsha Rao:
About Nurx: Nurx is a digital healthcare company offering 10 services across reproductive health, at-home testing, dermatology, migraine care, and more.
_______
Lin Jixun
Founder & CEO of ACON Laboratories
Lin Jixun has served as our director since 2008 and is the founder and chief executive officer of ACON Laboratories Inc., a worldwide leading manufacturer of high-quality rapid diagnostic test products. Mr. Lin founded ACON Laboratories Inc. in 1995 and serves on the company’s board of directors. He also serves on the board of directors for ACEA BioSciences Inc., a company providing innovative cell-based assay systems for basic life science research and drug discovery. Mr. Lin received his Ph.D. in microbiology and immunology from the Medical University of South Carolina and a Bachelor of Medicine from Zhejiang Medical University.
Follow Lin Jixun:
About ACON Laboratories: ACON Laboratories is a biotechnology firm that offers medical diagnostic and healthcare products.
Adam Karp
Co-Founder & CEO of Lively
Prior to Lively, Adam was the Chief Marketing Officer of 1stdibs – the world’s premier destination for unique, luxury design. At 1stdibs, Adam was instrumental in increasing the company’s revenue almost 10x; recruited and led a team of 100 and had full P&L responsibility for 1stdibs’ B2B business. Before 1stdibs Adam worked in senior roles at leading brands such as FreshDirect, Barnes & Noble and Century 21 real estate. At Century 21 he was responsible for developing and launching Century 21’s first website which at the time became the most recognized real estate website in the country and currently generates almost 50 million visits a year. After Century 21, Adam spent almost a decade at Barnes & Noble in increasingly senior roles ultimately becoming VP of Direct Marketing for both the retail stores and online. At Barnes & Noble, Adam managed some of the largest digital marketing programs in the industry, overseeing a budget of $100M. Adam graduated from the The Wharton School at the University of Pennsylvania with a degree in Economics.
Follow Adam Karp:
About Lively: Lively’s mission is to democratize, simplify and de-stigmatize the adoption and use of technically advanced hearing aids.
George Archos
Co-Founder, Chairman and CEO of Verano Holdings
George Archos is the founder & CEO of Verano Holdings. He is a logistics and operations guru. Building on his extensive experience in coordinating complex freight delivery operations, as well as designing and operating highly-successful restaurants, George entered the cannabis industry in 2014 when he founded Ataraxia Grow and Labs in Illinois and was the first to receive authorization to grow medical cannabis out of 21 recipients of the coveted medical licenses. George’s diligence, perseverance, and tireless work ethic have made him one of the cannabis industry’s most successful entrepreneurs. Leveraging his unparalleled devotion to quality and a unique results-oriented approach to the cannabis industry, George has overseen the development of some of cannabis’s most highly-coveted operations and brands. George’s restaurants across the Chicagoland area, including Wildberry Pancakes & Café, Westwood Tavern & Tap and the Scout Waterhouse & Kitchen, all bear the imprint of his relentless devotion to quality and unrivaled customer service, earning him multiple awards and recognition. George’s unique experience, his admirable drive, and his unrelenting commitment to quality, coupled with his capacity to establish, build, and effectively run multi-jurisdictional companies, are an asset to Verano Holdings.
Follow George Archos:
About Verano Holdings: Verano is a vertically integrated, multi-state cannabis operator.
Founder & CEO of Viome
Naveen Jain is an entrepreneur and philanthropist driven to solve the world’s biggest challenges through innovation. He is the founder of several successful companies including Moon Express, BlueDot, Viome, Intelius, TalentWise and InfoSpace. Moon Express is the only company to have permission from the US government to leave earth orbit and land on the moon. It’s developing technologies to harvest planetary resources on the moon for the benefit of humanity. BlueDot is focused on bringing most promising technological innovations from the national labs, NASA and elite universities and supercharging them with great entrepreneurs to create successful enterprises that tackle humanity’s grand challenges. Viome is focused on discovering predictive biomarkers to eradicate all diseases. Our initial goal is to provide personalized diet & nutrition based on deep analysis of microbiome, metabolome and meta genomics. Naveen Jain a trustee of the board and vision circle member at the X PRIZE Foundation where he is focused on finding entrepreneurial solutions to address the global challenges in health, education, women empowerment, agriculture, and energy. Naveen Jain is on the board of Singularity University, an interdisciplinary university with the mission to educate and inspire leaders to address humanity’s grand challenges through innovative technologies. Naveen Jain has been awarded many honors for his entrepreneurial successes and leadership skills including “Ernst & Young Entrepreneur of the Year”, “Albert Einstein Technology Medal” for pioneers in technology, “Humanitarian Innovation Award” at the United Nations, “Distinguished Global Thinker Award” by IILM, “Most inspiring Entrepreneur” by Andaaz TV, “Most admired Serial Entrepreneur” by Silicon India, “Top 20 Entrepreneurs” and “Lifetime Achievement Award” for the leadership in the technology industry and support of other entrepreneurs by Red Herring.
Follow Naveen Jain:
About Bellevue LifeSpring, BlueDot, Moon Express, TalentWise, Viome, World Innovation Inc: Viome is a provider of comprehensive health insights designed to help people track their gut microbiome health.
Yi Liu
Founder & CEO of iHealth Labs
Follow Yi Liu:
About iHealth Labs: iHealth offers cloud-based, personal healthcare products for individuals of all ages to take a more active role in managing their health.
David Ko
Co-founder and CEO of Ripple Health Group
David Ko is the Co-founder and CEO of Ripple Health Group (RHG), an early stage healthtech startup focused on helping people experience healthier lives by connecting them to the care, support, and community they need. Prior to RHG, David was the President, COO and Board Member of Rally Health, a digital health company that develops online and mobile solutions that make it easy for consumers to take charge of their health and health care. Rally’s solutions are currently available to nearly 55 million people through health plans, care providers, and more than 200,000 employers. Prior to joining Rally, David oversaw all strategy, planning and operations as COO at Zynga, which he helped take public in December 2011. At the time of its IPO, Zynga was the largest social gaming company in the world with over 100 million daily active users. Prior to his work at Zynga, he spent 10 years at Yahoo! in various senior executive roles, including SVP of Yahoo!’s audience, mobile, and local businesses. David serves on the board of overseers at his alma mater New York University Stern School of Business where in 2016 he established the NYU Stern Venture Fellows program for aspiring entrepreneurs. He also works as an advisor and investor to a number of companies in Silicon Valley including Calm, the number one app for Sleep, Meditation and Relaxation.
Follow David Ko:
About Audax Health Solutions, Calm, Ripple Health Group: Ripple Health Group is a platform for the world’s most trusted healthcare solutions.
Eric Moskow
Chief Executive Officer, Director of Accuity Delivery Systems
Founder, CEO and Executive of several highly successful healthcare ventures; including DDDS, OBDS, and Cybear. Dr. Moskow is recognized as an innovative leader in the efficient operation of medical practices. He formed Outcome Based Delivery Systems, with operations in South Florida, Orlando, Florida and Las Vegas, Nevada, which OBDS sold in October 2011. From its founding in 2006 through the sale of its operations, OBDS built its revenue base from a run rate of $0 in 2006 to more than $80M in 2011. He formed Coral Gate Medical Group, a medical practice in Broward County, Florida, in January 2002 and has operated as its Managing Partner since inception. From 2002 to 2005, Coral Gate’s revenues increased from $350,000 to $3.5 million. From February 2000 through January 2002, Dr. Moskow served as Executive Vice President of Cybear, an information technology company serving the health care industry formed by Andrx Corp. He served as a Director of Cybear from June 1999 to 2002. From September 1996 to January 2000, Dr. Moskow was Executive Vice President of Strategic Planning for Phymatrix, a publicly-traded multi-specialty medical provider network. In addition, during this period and then through March 2002, he served as a Director of Phymatrix and its successor, Innovative Clinical Solutions, Ltd. (“ICSL”). From 1989 to 1997, Dr. Moskow served as an Internist and President of Family Medical Associates in Ridgefield, Connecticut. During part of this same period, from October 1995 to October 1996, Dr. Moskow served as Executive Vice President of Physician’s Choice Management, LLC (“PCM”), which he co-founded. In addition, from 1988 to 1992, Dr. Moskow served as Associate Medical Director in Connecticut for U.S. Healthcare. Dr. Moskow is board certified in internal medicine. He received his B.S. degree from Vassar College in 1980 and his M.D. degree from New York Medical College in 1984.
Follow Eric Moskow:
About Accuity Delivery Systems: Accuity Delivery Systems is a provider of clinical documentation services for the healthcare industry.
Stephanie Tilenius
CEO, Founder of Vida Health
Stephanie is CEO & Founder of Vida Health.
Follow Stephanie Tilenius:
About Nextdoor, Vida Health: Vida Health is a virtual care platform that provides health coaching from experienced health care providers and medical institutions.
Aaron Kaufman
CEO & Chairman of OpenMed
Follow Aaron Kaufman:
About : OpenMed is a digital innovator in closing care gaps, enabling access to care, and supporting real-time collaboration.
Raja Dhir
Co-Founder and Co-CEO of Seed Health
Raja Dhir is a life sciences entrepreneur and Co-Founder of Seed Health, a venture-backed microbiome company pioneering the application of bacteria for both human and planetary health. He leads Seed’s R&D, academic collaborations, technology development, clinical trial design, supply chain, and intellectual property strategy. Together with Dr. Jacques Ravel, he Co-Chairs Seed’s Scientific Advisory Board–an interdisciplinary group of scientists and doctors who lead research teams and teach at institutions including the teaching hospital of Harvard Medical School and the Trial Innovation Unit of Mass. General Hospital (MGH). Raja has designed clinical trials with leading academic institutions including the teaching hospital of Harvard Medical School and the Trial Innovation Unit of Mass. General Hospital (MGH). Raja has unique expertise translating scientific research for product development with a track record that includes patented inventions to stabilize sensitive compounds to improve alpha-diversity of the gut microbiome (derived from micro-algae) and most recently, the co-invention of microbial technologies to protect honeybee populations (Apis mellifera) from neonicotinoid pesticides and pathogen colonization. His work also includes biofermentation and scale-up for both facultative and strict anaerobic organisms. Raja has negotiated multiple joint-ventures, strategic partnerships, technology transfer and licensing agreements with publicly traded companies (NYSE, LSE) and academic institutions (Harvard Medical School, UCLA). To date, entities he has co-founded own the rights to 15+ patents and research emerging from $25MM+ of non-dilutive funding over 10+ years from the Bill and Melinda Gates Foundation and National Institute of Health (NIH). Raja serves on the Editorial Board for the scientific journal, Microbiome. He is a member of the Microbiome Think Tank at Mass. General Hospital (MGH) and sits on the Advisory Committee for the International Scientific Association of Probiotics and Prebiotics (ISAPP). Raja is also a Director and Co-Chair of the Scientific Advisory Board for Micropia, a $20MM microbial ecology / education platform and the world’s first museum dedicated to microbes.
Follow Raja Dhir:
About Seed Health: Seed Health is a microbial company that focuses on therapeutics, consumer health innovations, and environmental solutions.
Ara Katz
Co-Founder and Co-CEO of Seed Health
Ara Katz is the Co-Founder and Co-CEO of Seed Health, a microbial sciences company pioneering the application of bacteria to impact human and planetary health. She has worked at the intersection of technology, consumer, design, and media is now working to steward a new standard in probiotics and how science is communicated to change how we discern evidence from evangelism to make the most informed choices for our bodies, our health, and our world. Ara previously co-founded and served as CMO of mobile commerce marketplace, Spring (backed by LMVH, sold to ShopRunner), and was on the founding team of social commerce company, BeachMint (sold to Conde Nast), where she launched six direct-to-consumer, influencer subscription brands. She is an angel investor and advisor in companies such as mindbodygreen, Stadium Goods (recently sold to FarFetch), RXDefine, women’s healthcare startup, Mahmee, and new biomaterials company, C16. Ara has been a fellow at the MIT Media Lab’s Center for Future Storytelling and CCA’s Design MBA program, was named in Marie Claire’s “The New Guard: The 50 Most Influential Women in America”, listed on Business Insider’s “Silicon Alley Top 100” and “36 Rockstar Women in NYC Tech”, and Create + Cultivate’s 100 List for STEM.
Follow Ara Katz:
About Seed Health: Seed Health is a microbial company that focuses on therapeutics, consumer health innovations, and environmental solutions.
Thomas Joyce
President & CEO of Danaher
Thomas Joyce is President and Chief Executive Officer of Danaher Corporation, a position he assumed in September 2014. Thomas is responsible for the company’s strategic vision and leads the development and growth of Danaher’s global science and technology portfolio. Thomas has more than 20 years of Danaher leadership experience. Prior to his appointment as President and Chief Executive Officer, he served as Executive Vice President of Danaher Corporation, responsible for Danaher’s Water Quality platform and Life Sciences & Diagnostics segment. In this role, Thomas increased Danaher’s Water Quality revenue by over $1.5 billion and led the company’s major acquisitions of Beckman Coulter and AB SCIEX. Throughout his tenure, Thomas has also played a key role in developing and evolving the Danaher Business System, Danaher’s common operating philosophy. Thomas began his Danaher career in 1989 as a Project Manager in the Danaher Tool Group, and later transitioned into a manufacturing role. In 1995, Thomas became President of Delta Consolidated Industries. Following this assignment, he became President of Hach Company, the world leader in analytical instrumentation for drinking water and wastewater applications in 2001. In 2002, Thomas became a Group Executive and Corporate Officer with Danaher Corporation, which led to his transition to Executive Vice President in 2006. Prior to joining Danaher, Thomas worked as a management consultant at Anderson Consulting, where he worked with a large number of manufacturing businesses to implement lean tools and optimize transactional processes. Thomas was born and raised on the north shore of Chicago and earned his bachelor’s degree in Economics from the College of the Holy Cross in 1982. He and his wife, Claire, live in Washington, D.C. and have four children.
Follow Thomas Joyce:
About Danaher: Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Stephen Hadley
Chief Executive Officer of Pathway Partners Vet Holding
Prior to joining Pathway as Chief Executive Officer in 2017, Dr. Stephen Hadley served as Chief Operating Officer for BluePearl and Chief Strategy Officer for MedVet. He is the founder of TenTalents Capital, LLC, founding Director of VCA Specialty Animal Hospitals, and served as Group Vice President with VCA for 12 years. Dr. Hadley also founded the Aquarium of the Pacific in Long Beach. He earned his BS, MS and DVM degrees from the University of Illinois in Champaign-Urbana, IL followed by a surgical internship and residency in Los Angeles. He later earned an MBA from The Wharton School at the University of Pennsylvania.
Follow Stephen Hadley:
About Pathway Partners Vet Holding: Pathway Vet Alliance is a veterinary hospital owner and operator.
Hari Sundram
Chief Executive Officer of Radion Health
Follow Hari Sundram:
About QMedic, Radion Health: Radion Health offers turnkey stop-loss solutions to brokers, consultants, and TPAs.
Brenton Saunders
Chairman, President and Chief Executive Officer of Allergan
Brent Saunders is Chief Executive Officer and President of Allergan plc (formerly Actavis plc). Brenton previously served as Chief Executive Officer and President of Forest Laboratories and had served as a Member of the Board of Directors at Forest since 2011. Brenton has significant healthcare industry expertise and a proven track-record leading business transformations and integrations. Prior to Forest, Brenton was Chief Executive Officer of Bausch + Lomb, a leading global eye health company, serving in this capacity from March 2010 until August 2013. Brenton also held a number of leadership positions at Schering-Plough, including the position of president of Global Consumer Health Care and was named head of integration for the company’s merger with Merck & Co. and for Schering-Plough’s acquisition of Organon BioSciences. Before joining Schering-Plough, Brenton was a Partner and Head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, Brenton was Chief Risk Officer at Coventry Health Care and Senior Vice President, Compliance, Legal and Regulatory at Home Care Corporation of America. Brenton began his career as Chief Compliance Officer for the Thomas Jefferson University Health System. Brenton serves on the Board of Trustees of the University of Pittsburgh. Brenton is also the former Chairman of the New York chapter of the American Heart Association. Brenton is a Member of the Business Council and PhRMA. Brenton earned his MBA from Temple University School of Business, his J.D. from Temple University School of Law and his Bachelor’s degree from the University of Pittsburgh.
Follow Brenton Saunders:
About Allergan, Cisco: Allergan is a global pharmaceutical company.
Charlie Bachtell
Founder and CEO of Cresco Labs
Charles Bachtell serves as Co-Founder and Chief Executive Officer at Cresco Labs, LLC. He served as an Executive Vice President and General Counsel at Guaranteed Rate, Inc. Charles Bachtell served as the head of the legal and loss mitigation departments at Guaranteed Rate. He managed matters concerning legal, regulatory/legislative compliance, credit risk, corporate governance, and acquisitions, among others. Additionally, he is a board member of the Guaranteed Rate Foundation, the company’s nonprofit (501 c3) arm. Charles Bachtell worked with Guaranteed Rate. He obtained his Bachelor of Science degree in business administration with an emphasis in finance from the University of Arizona from 1996 to 2000 and his Juris Doctor from DePaul University College of Law.
Follow Charlie Bachtell:
About Cresco Labs: Cresco Labs is a vertically-integrated multi-state cannabis operator inciting the progressive evolution of the medical cannabis industry.
Abilash Krishna
Co-founder & CEO of CareStack
Abhi is a visionary entrepreneur who brings a decade of expertise building technology platforms in US healthcare. His business acumen, decision making, and analytical skills are shaping CareStack to be a force in the dental and retail healthcare space.
Follow Abilash Krishna:
About CareStack: CareStack is a practice management platform for dental groups to manage all of their software and daily operations through one platform.
David Kopp
Chief Executive Officer of Healthline Media
David leads the Healthline Media team. His 25 year career spans publishing, digital advertising, consumer services, and clientside marketing for both big brands (Disney and Yahoo!) as well as more entrepreneurial ventures. David believes that people need better tools, education, and support in order to achieve good health, and he’s confident that Healthline’s purpose-driven team will make the world stronger and healthier. He also talks a lot about sugar: if you want to live a long, healthy life, minimize your sugar intake.
Follow David Kopp:
About Healthline Media: Healthline Media is the 2nd largest and fastest growing consumer health publisher in the world, reaching 85 million people a month.
Sam Santhosh
Founder Chairman & Global CEO of MedGenome
Sam Santhosh is the Founder and CEO of MedGenome. He has been an entrepreneur, with over 20 years of experience in the software industry. Currently, he is at the helm of affairs as CEO and promoter of MedGenome Labs Pvt Ltd. Sam sits on the board of a number of companies, both in the US and India. In this role he advises, guides and mentors companies to help them grow and realize their true potential. Prior to this Sam was the CEO and Managing Director of California Software Limited (Calsoft) from 1992 – Feb 2012. He founded Calsoft in 1992 and under Sam’s vision, Calsoft rapidly grew from a niche player in the Silicon Valley to a global player with over 1200 employees and presence in 8 countries. Sam took Calsoft Public and the company is listed the in Indian Stock Exchanges. Sam oversaw the growth of Calsoft in all key areas – Finance, Strategy, Customer Acquisition, and inorganic growth through eight acquisitions including companies in the U.S, UK, Japan, and India. He has been constantly retooling himself and has attended various training programs in different U.S universities including MIT. In 2010, he completed the Executive Education program at the Singularity University in Sunnyvale, California. Sam has an engineering degree and an MBA (majoring in Management Information Systems) from India’s premier institute, IIM Calcutta.
Follow Sam Santhosh:
About Agrigenome, MedGenome: MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.
Brent Clements
Founder & CEO of Addiction Campuses of America
Brent is an accomplished entrepreneur, executive, and healthcare visionary. With over 20 years experience in senior leadership roles for multiple organizations in the healthcare and technology industries, Brent has a clear plan for what is required to build a successful company. Brent’s passion for helping those families in need inspired the founding of Addiction Campuses. Throughout his professional career Brent has developed expertise in creating strategy for the future, maximizing organizational efficiency, and building relationships with care givers, employees and community partners who drive change. Ultimately Brent believes “If they change the core belief system, the mindset changes and good behavior follows”. That is what Addiction Campuses is all about. He was recognized as one of Nashville Business Journal’s 40 Under 40 in 2011 and Healthcare Heroes nominee in 2010. Brent is married to his wife, Vicki, and they have two sons.
Follow Brent Clements:
About Addiction Campuses of America: Addiction Campuses of America owns, operates and manages behavioral healthcare campuses across the United States.
Alexander Isakov
Founder & CEO of Lattis Surgical
Follow Alexander Isakov:
About Lattis Surgical: The Lattis team developed a Contained Tissue Extraction (CTE) device, using bladeless technology.
Brad Packer
Founder and CEO of Vitality Medical
Brad is the brains behind it all. Brad started Vitality Medical in 2000 shortly after completing his graduate degree from Medical College of Virginia. While employed as a registered nurse Brad recognized the need for online medical supplies and seized the opportunity to start Vitality Medical. Working weekend nights as a nurse and weekdays as entrepreneur Brad and his team of dedicated co-workers have created one of the foremost leading companies in the online medical supply market.
Follow Brad Packer:
About Vitality Medical: Vitality Medical provides quality home medical supplies and hospital equipment.
Christopher Morris
Founder & CEO of Daybreak Health
Christopher is an Internal Medicine and HIV specialist at NYU Langone Medical Center focused on digital health innovations as means to transform health care quality and access. He is most interested in using emerging telehealth technologies to transform the primary care experience.
Follow Christopher Morris:
About Daybreak Health, NYU Langone Health, NYU Langone Medical Center: Daybreak Health is a digital health platform that facilitates mobile care solutions.
William F McKeon
CEO of Texas Medical Center
Mr. William F. McKeon serves as the Chief Executive Officer of Texas Medical Center in Houston, TX. Prior to joining the TMC leadership, he was the CEO of Cellnovo Limited. Mr. McKeon served as President of MicroPort Medical (Shanghai) Co. Ltd. since August 2006. He joined MicroPort Medical Co. Ltd. in 1997, where he was responsible for its marketing, eCommerce and eHealth initiatives. His professional career began at Du Pont where he held several marketing and business development roles in the United States and Europe. Prior to joining MicroPort Medical Co.
Follow William F McKeon:
About Texas Medical Center: Texas Medical Center (TMC) is a life sciences medical complex focused on patient care, research, education, and prevention.
Robert C Robbins
President and CEO of Texas Medical Center
Robert C. Robbins became President and Chief Executive Officer of Texas Medical Center on November 5, 2012. Prior to that, he was professor and chairman of the Department of Cardiothoracic Surgery at Stanford University School of Medicine, where he served as a member of the faculty since 1993. He served as director of the Stanford Cardiovascular Institute, of the Heart- Lung and Lung Transplantation Programs, and of the Cardiothoracic Transplantation Laboratory. Dr. Robbins is an internationally recognized cardiac surgeon who has focused his clinical efforts on acquired cardiac diseases with a special expertise in the surgical treatment of congestive heart failure. His research work includes the investigation of stem cells for cardiac regeneration, cardiac transplant allograft vasculopathy, bioengineered blood vessels, and automated vascular anastomotic devices. He served as the guest editor of the Circulation Surgical Supplement from 2002 to 2005, president of the International Society of Heart and Lung Transplantation in 2006, president of the Bay Area Society of Thoracic Surgeons in 2006, chair of the American Heart Association Cardiovascular Surgery and Anesthesia Council from 2007 to 2009, councilor-at-large for the Western Thoracic Surgical Association from 2007 to 2009, and on the President’s Cabinet at California Polytechnic State University from 2006 to 2012. In California, he served on the Board of Directors for two publically traded companies, Cohesion Technologies from 2000 to 2003 and Cardica, Inc. from 2000 to2009, and as a director for several other privately held Bay Area biotechnology companies. In 2009, he was elected to the American Heart Association Western States Affiliate Board of Directors and currently serves as president of the organization. He was elected to the Board of Trustees of Millsaps College in Mississippi in 2010. Dr. Robbins has lectured widely and published more than 292 peer reviewed articles. He earned his bachelor’s degree in chemistry from Millsaps College in 1979 and a medical degree from the University of Mississippi in 1983. He completed his general surgical training at the University of Mississippi in 1989 and his cardiothoracic training at Stanford University in 1992. Dr. Robbins completed post-doctoral research at Columbia University and the National Institutes of Health, and congenital heart surgical fellowships at Emory University and Royal Children’s Hospital. An ex-officio of the Houston Livestock Show & Rodeo, Dr. Robbins currently sits on the Advisory Board of the Ronald McDonald House in Houston and on the Board of Directors for Texas Medical Center, the Greater Houston Partnership, the Greater Houston Convention and Visitors Bureau, the Houston Academy of Medicine Texas Medical Center Library, the Houston Technology Center, and the Friends of Houston Academy of Medicine Texas Medical Center Library.
Follow Robert C Robbins:
About Texas Medical Center: Texas Medical Center (TMC) is a life sciences medical complex focused on patient care, research, education, and prevention.
Derek Lampert
Chief Executive Officer of Drive Medical
Follow Derek Lampert:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
James Flynn
Managing Partner & CEO of Deerfield Capital Management
Jim is the Managing Partner of Deerfield. He joined Deerfield in 2000, focusing on pharmaceutical companies and gradually assuming broader responsibility throughout the firm. In 2004 Jim began co-managing the firm with Deerfield’s founder, Arnold Snider. Upon Arnie’s retirement in 2005, Jim assumed his current role overseeing Deerfield’s investment activities as well as the management of the firm. Since that time, the firm has expanded its investment capabilities to include private structured financings, developed additional proprietary market research instruments through the Deerfield Institute, and created the Deerfield Foundation to contribute toward the health and welfare of disadvantaged children. Before joining Deerfield, Jim was a top ranked analyst at Furman Selz from 1996 to 2000, where he built a team to cover the pharmaceutical and medical device industries and also managed a proprietary trading account. Previously he served from 1993 to 1996 as Vice President of Corporate Development of Alpharma Inc., a pharmaceutical company, where his responsibilities included business development and strategic planning and the management of several licensing transactions. Jim began his career in healthcare investing from 1988 to 1993 at Kidder, Peabody & Co., where he ultimately served as a senior analyst covering the specialty pharmaceutical industry. Since 2009, Jim has served as the Chairman of the Quality Committee of the Board of Trustees of Continuum Health Partners until its merger in 2013 with Mount Sinai Health System, where he continues to serve on the Board of Trustees. He also serves on the Board of Trustees of the New York Academy of Medicine. He holds a B.S. in Cellular and Molecular Biology and Economics from the University of Michigan.
Follow James Flynn:
About Deerfield, Deerfield Capital Management, Deerfield Management, SaveologyHomeServices.com: Deerfield Capital Management (DCM) is a global fixed-income investment adviser
Andrew Hayek
Chief Executive Officer of UnitedHealth Group
Andrew Hayek has served as our Chief Executive Officer since 2008. Prior to joining SCA, Andrew served as the President of a division of DaVita Healthcare Partners (a renal dialysis and medical group provider), as President and Chief Operating Officer of Alliance Healthcare Services (a diagnostic imaging and radiation therapy provider), and in roles at Kohlberg Kravis Roberts & Co. (a global investment firm) and the Boston Consulting Group (a global management consulting firm). Andrew is a Henry Crown Fellow at the Aspen Institute and serves as Chairman of SCA Medical Missions (a surgical mission program). Andrew also serves as Chief Executive Officer of OptumHealth, one of three segments of Optum and the one that includes SCA. Andrew earned a Bachelor of Arts summa cum laude from Yale University.
Follow Andrew Hayek:
About Firsthand, UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Stefano Migliorisi
Founder & CEO of swyMed Incorporated
Follow Stefano Migliorisi:
About swyMed Incorporated: swyMed’s solutions power truly mobile, real-time video telemedicine encounters at the lowest bandwidths.
Tom Nix
CEO of Ria Health
Follow Tom Nix:
About Ria Health: Ria Health’s evidence-based telehealth alcohol treatment program helps people drink less and live better.
Paul Chang
President, CEO/CSO and Lead Founder of ARase Therapeutics
Follow Paul Chang:
About ARase Therapeutics: Arase Therapeutics is a science-focused oncology company developing therapies that modulate cancer-relevant cell signaling pathways.
Bridget Osetinsky
Founder & CEO of Hyperfine
Bridget is the Founder and Chief Executive Officer of Hyperfine. She earned her Juris Doctor from Temple University James E. Beasley School of Law in 2011 and her Bachelor of Science in Physics from the University of Notre Dame in 2007.
Follow Bridget Osetinsky:
About Hyperfine: Advanced Analytics For Precision Medicine
Jiang Li
CEO of VivaLnk
Jiang has both passion and extensive experience in bringing innovative technology and products into the marketplace. He has held various senior management positions in both large high tech organizations and startup companies. Prior to joining VivaLnk, he was responsible for new product and technology development as the VP of engineering in Kovio and Thinfilm Electronics, leading printed electronics companies. Prior to that, he worked at AMD and the joint venture between AMD/Fujitsu, Spansion. As the VP of product engineering in Spansion, Jiang managed the major new product launches in Spansion. Jiang holds a Ph.D. degree from the University of Wisconsin-Madison, and a bachelor’s degree from Zhejiang University in China.
Follow Jiang Li:
About VivaLnk: VivaLnk is a provider of connected healthcare solutions for in-patient and remote patient monitoring.
David Cordani
President & CEO of Cigna
David Cordani is the President (since 2008) and Chief Executive Officer at Cigna since December 2009. David is also a Member of the Board of Directors at Cigna since 2013. David has led Cigna’s transformation from a traditional health insurer into a leading, global health service company, with a focus on helping people improve their health, well-being and sense of security. Since becoming President and Chief Executive Officer in 2009, Cordani has successfully galvanized Cigna’s more than 35,000 employees–in more than 30 countries–around a global product and service repositioning, guided by the company’s differentiating “Go Deep, Go Global, Go Individual” strategy. Previously, David was the Chief Operating Officer from June 2008 until December 2009, President of Cigna HealthCare from 2005 until 2008 and Senior Vice President of Customer Segments and Marketing for Cigna HealthCare from 2004 until 2005. David has been employed by Cigna since 1991. David is an accomplished triathlete, having competed in more than 125 triathlons. David earned a Bachelor’s degree from Texas A&M University and an MBA from the University of Hartford.
Follow David Cordani:
About Cigna: CIGNA Corporation operates as a health service company that helps people to improve the health, well-being, and peace of mind.
Sahil Diwan
Co-Founder & CEO of SafKan Health
Follow Sahil Diwan:
About SafKan Health: Ear care for the 21st century.
Paul Johnson
CEO of Lemonaid Health
Paul is the co-founder and CEO of Lemonaid Health. He moved from the UK to the US in 2014. In the UK Paul’s entrepreneurial career started aged 17 where I was a runner up in a Daily Mail sponsored entrepreneur of the year competition and founded his first company ran from the garage of his family home. Later Paul founded and ran the UK’s largest online pet retailer and became Head of Online for the second largest drugstore chain. Paul continues to advise McKinsey & Company and others on e-commerce, innovation and business strategy. In the UK Paul was an advisor to the Government on Entrepreneurism and Enterprise.
Follow Paul Johnson:
About Lemonaid Health: Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
David E. Weekly
CEO of Medcorder
David is a nerd who likes people. David runs the product org for the datacenter software team at Google and previously helped launch internet.org at Facebook, helping to connect the species to the Internet. Before that, he started and ran Ohana (a service to help parents share videos of their kids with extended family) and PBwiki (the first private hosted wiki company), still used by millions of people a month. He was the Founding Director of Hacker Dojo, one of the world’s largest hackerspaces, located in Mountain View, and was the Founding Partner of Mexican.VC, Silicon Valley’s first seed fund for Mexican Internet startups and the best performing Mexican tech fund in history. David has been programming since he was five and graduated from Stanford with a degree in Computer Science as a President Scholar. He has worked in such widely varying technology environments as Harvard Physics Labs, MIT Lincoln Labs, Stanford Graphics Labs, atWeb (acquired by Netscape), myplay (acquired by Bertelsmann), Legato (acquired by EMC), and There.com (where he worked with Eric Ries, the inventor of The Lean Startup methodology). David has served as an advisor to dozens of technology companies, including Plaxo (acquired by Comcast), Attassa (acquired by YouSendIt), and Like.com (acquired by Google).
Follow David E. Weekly:
About Medcorder: Medcorder is a mobile app that helps families to coordinate and communicate about patient care.
Francis deSouza
CEO of Illumina
Francis A. deSouza, 50, has been President and Chief Executive Officer of Illumina, Inc., a biotechnology company, since 2016 and served as President of Illumina from 2013 to 2016. Prior to joining Illumina, Mr. deSouza was President, Products and Services, of Symantec Corporation from 2011 to 2013, and Mr. deSouza served as Symantec’s Senior Vice President, Enterprise Security Group, from 2009 to 2011. Prior to that time he founded or worked in a variety of other technology businesses. He has served as a Director of Illumina since 2014 and was a director of Citrix Systems, Inc. from 2014 to 2016. He was elected a Director of the Company in December 2017, effective February 1, 2018.
Follow Francis deSouza:
About Illumina: Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Jay Flatley
President & CEO of Illumina
Jay was appointed President and CEO of Illumina in 1999 and oversaw the company’s expansion into the whole genome sequencing area with the acquisition of Solexa in 2006, and more recently into diagnostics and consumer sequencing. Under his leadership, Illumina has been named multiple times to the Deloitte & Touche Fast 50 and Fast 500 lists, as well as to the Forbes 25 Fastest-Growing Tech Companies (2007, 2009 and 2010), the Fortune 100 Fastest-Growing Companies (2010 and 2011) lists, and recognition by MIT Technology Review as the World’s Smartest Company in 2014. Previously, Jay served as President and Chief Executive Officer of Molecular Dynamics. As a co-founder and member of the board of directors for Molecular Dynamics he led the company to its initial public offering in 1993. He helped Molecular Dynamics develop and launch over 15 major instrumentation systems, including the first capillary-based DNA sequencer. Currently, he is an Advisory Board member for UC San Diego’s Moores Cancer Center, and a member of the Board of Directors at Coherent, Denali, and Illumina, Inc. Jay received a B.A. in economics from Claremont McKenna College and a B.S. and M.S. (summa cum laude) in industrial engineering from Stanford University.
Follow Jay Flatley:
About Illumina: Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Erik Holmlin
President, CEO of Bionano Genomics
Erik Holmlin has two decades of experience in the life science and health care industries. His expertise spans technology development and commercialization, global marketing, commercial operations, venture financing, mergers & acquisitions and intellectual property. Recently, he served as president and CEO of GenVault Corporation, a life science company bring innovative solutions to biosample management. He merged GenVault with IntegenX, Inc. in January of 2011. He also served as an entrepreneur in residence (EIR) at Domain Associates, LLC, a leading dedicated life science venture-capital firm. Prior to these roles, Erik was chief commercial officer at Exiqon A/S, where he was responsible for global sales, marketing, and clinical affairs for two businesses: Oncology Services in a CLIA lab and Consumables Business in Life Sciences Research. In 2001 Mr. Holmlin led the formation of GeneOhm Sciences, Inc., for which, over a span of 5 years, he was director of chemistry, senior technology director, vice president of technology and business development, and vice president of marketing.
Follow Erik Holmlin:
About Bionano Genomics: BioNano Genomics develops nanoscale imaging and analytic platforms designed to analyze DNA and other genome-related peptides and proteins.
Mingzhe Ma
Chairman and CEO of Ping An
Mingzhe Ma is the founder of the Company. Mingzhe Ma founded Ping An Insurance Company in March 1988, and is the current Chairman and CEO of the Company. Since the establishment of the Company, Mingzhe Ma has served as President, Director, Chairman and CEO of the Company, and has been in charge of operations and management of the Company. Before establishing the Company, Mingzhe Ma was Deputy Manager of China Merchants Shekou Industrial Zone Social Insurance Company. Mingzhe Ma has a doctor’s degree in money and banking from Zhongnan University of Economics and Law (previously Zhongnan University of Economics).
Follow Mingzhe Ma:
About Ping An, Ping An Healthcare Management: Ping An Insurance Company is a holding company deals with insurance, banking, and financial service.
Simba Gill
President & CEO of Evelo Biosciences
Simba Gill, PhD is an entrepreneur, investor and CEO who believes passionately that science and globalization will dramatically improve life in the 21st century. Dr. Gill is currently the CEO of Evelo, Sr. Partner at Flagship Ventures, and Executive Chair of Blackfynn. Dr. Gill founded or had lead roles in moksha8, Epirus, Maxygen, Verdia, Avidia, Codexis, Systemix and Valentis, four of these companies have been taken public and three were acquired through strategic trade sales. Exit valuations were between $400M – $6B. Dr. Gill has also led, built and launched several commercial businesses/products generating annual revenues of between $150M-$2B. Dr. Gill has founded and/or had lead roles in pioneering companies in the fields of antibodies, stem cells, directed molecular evolution, immunodiagnostics and the cancer microbiome. He has also been an investor, advisor, founder and CEO of several emerging market life science companies. Dr. Gill was a Partner at TPG, focused on investments in Life Sciences and Emerging Markets. Early in his career, Dr. Gill was co-head of Worldwide Marketing for Recormon. He also led corporate and market development and strategy from inception to commercialization of the Elecsys system, which became one of the world’s most widely used immunodiagnostic platforms. Dr. Gill served on the Board of Directors of the Tuberculosis Alliance, The Djerassi Resident Artists Program and the International Advisory Board of INSEAD. Dr. Gill was also the founder of Dispatches, an in-depth written and photojournalism periodical focused on key global issues. Dr. Gill has an MBA from INSEAD and carried out his PhD with focus on developing humanized antibodies to treat cancer. This work was done at King’s College, London in collaboration with the LMB at Cambridge and Celltech.
Follow Simba Gill:
About Epiva, Evelo Biosciences, moksha8 Pharmaceuticals, TPG Growth: Evelo Biosciences is dedicated to improving the lives of patients globally through the development of monoclonal microbials.
Daniel Grau
President, Chief Executive Officer, and Director of Sojournix
Grau co-founded and has served as Chief Executive Officer and Director at Sojournix since 2016. An experienced biotech entrepreneur and operating executive, Mr. Grau led the deal to acquire SJX-653 and has driven the rapid growth and financing of the company from startup to clinical-stage pharmaceutical business. Prior to Sojournix, Mr. Grau served as President at Heptares Therapeutics (acquired 2015), Chief Executive Officer at Cortria (acquired 2010), and Chief Operating Officer at CombinatoRx (IPO 2005). Mr. Grau currently serves as an advisor to HotSpot Therapeutics and previously served as a member of the Product Advisory Board at Concert Pharmaceuticals and as an advisor to Nimbus Therapeutics. Earlier in his career, Mr. Grau worked with multi-national pharma companies as a management consultant focused on corporate and business franchise strategy, M&A, and new product launches. Mr. Grau earned his M.Phil., M.A., and M.A.R. degrees from Yale University, where he was awarded a Mellon Fellowship, the Day Graduate Prize, and a Bass Fellowship, and a B.A. with High Honors from Davidson College, where he held a Dana Honor Scholarship, a Montgomery Scholarship, and was elected to Phi Beta Kappa.
Follow Daniel Grau:
About Cortria Corporation, Heptares Therapeutics, Sojournix: Sojournix is a biotechnology company developing innovative medicines for women’s health and endocrine disorders.
Pamela Sedmak
CEO of Aetna Medicaid of Aetna
Pamela Sedmak is the former senior Vice President and Chief Financial Officer for Blue Cross/ Blue Shield of Minnesota. She was responsible for all facets of financial operations at Blue Cross including business development, budgeting, forecasting, reporting and analysis. She has been honored as a Hall of Fame inductee by the Anderson School of Management at the University of New Mexico and has been very involved in professional and community associations including being a founding member of the Greater Cleveland Executive Women’s Leadership Forum. She received her degree in finance from the University of New Mexico and her M.B.A. in Executive Management from Case Western Reserve University in Ohio.
Follow Pamela Sedmak:
About Aetna: Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Mark Bertolini
Chairman and Chief Executive Officer of Aetna
Mark Bertolini is Chairman, Chief Executive Officer and President of Aetna, a Fortune 100 diversified health care benefits company with more than $47.2 billion in 2013 revenue. Aetna serves an estimated 44 million people with information and resources to help them make better informed decisions about their health care and has operations in North America, Asia, Europe and the Middle East. Bertolini assumed the role of CEO on November 29, 2010 and of Chairman on April 8, 2011. Bertolini joined Aetna in 2003 as head of Aetna’s Specialty Products. In July 2007, he was named president, responsible for all of Aetna’s businesses and operations across the company’s broad range of health care products and related services – including medical, pharmacy, dental, behavioral health, group life and disability plans, as well as medical management capabilities and health care management services for Medicaid plans. Prior to serving as Aetna’s president, Bertolini was executive vice president and head of Aetna’s regional businesses, which included the company’s individual, retiree, small group and middle market segments, as well as numerous product, network and service areas. Recognized as an accessible, forward-thinking and solutions-oriented leader, Bertolini is actively engaged in the national dialogue on health care reform, meeting regularly with state and federal policymakers to advocate for measures that increase access, lower costs and improve quality of health care. He is a strong advocate of market-based solutions, the expansion and use of health information technology, and the sustainability of the employer-based system. Firmly committed to diversity and inclusion, Bertolini also serves as the company’s executive sponsor for diversity, participates in several Aetna employee resource groups, and maintains a blog to communicate with employees. Among his civic activities, Bertolini serves on the Board of Directors of the U.S.-China Business Council, the Hole in the Wall Gang Camp, an organization founded by Paul Newman that serves children with cancer and other serious illnesses, and FIDELCO, an organization that breeds and trains guide dogs for the visually disabled. In 2009, he was elected the first straight ally board member of the National Gay and Lesbian Chamber of Commerce. Bertolini has been honored for his leadership by numerous universities and organizations, including the National Italian American Foundation, Outward Bound, the National Kidney Registry, Out & Equal Workplace Advocates, the Quinnipiac University Business School, and Wayne State University School of Business. Prior to joining Aetna, Bertolini held executive positions at Cigna, NYLCare Health Plans, and SelectCare, Inc., where he served as president and chief executive officer. Born and raised in Detroit, Bertolini held various jobs throughout high school and college, including assembly work at a Ford Motor Company plant and various caregiver roles in health care delivery.Bertolini is a spinal cord injury survivor and is partially disabled as the result of a severe skiing accident in 2004. In 2007, Bertolini donated a kidney to his son. His previous work and personal experiences with the health care system are foundational to his dedication to improving the patient experience and addressing the longstanding challenges facing the U.S. health care system. Bertolini holds an undergraduate degree in business administration/finance from Wayne State University and a MBA in finance from Cornell University.
Follow Mark Bertolini:
About Aetna: Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Nicholas Chang
CEO & Founder of The Pill Club
Follow Nicholas Chang:
About The Pill Club: The Pill Club provides online birth control prescription and at-home delivery services.
Seth Sternberg
Co-Founder & CEO of Honor
Seth Sternberg is the Co-Founder and CEO of Honor, a non-medical home care company with a mission to enable our parents to remain in their homes as they age. Prior to Honor, Seth was the Co-Founder and CEO of Meebo, which brought instant messaging to the web and reached close to half the internet population in the United States. Meebo was acquired by Google, where Seth became a Product Director working on the Google Identity Platform, and then within GoogleX. Seth started his career with IBM’s Corporate Development group after graduating from Yale.
Follow Seth Sternberg:
About Honor, Meebo: Honor is a senior care network and technology platform that offers personalized care to improve the in-home care experience.
Roy Paxton Yih
Co-Founder and CEO of Biocare Medical
Roy Paxton Yih, BS, MA, co-founded Biocare Medical, LLC in 1997 and serves as its Chief Executive Officer and President. Roy Yih served as a Director of Sales & Marketing at Biocare Medical LLC. Roy Yih is primarily involved at sales, marketing and business development activities. He holds a BS Degree in Biochemistry from U.C. Davis and an MBA from the University of Santa Clara.
Follow Roy Paxton Yih:
About Biocare Medical: Biocare Medical is a provider of immunohistochemistry instrumentation.
Chris Mansi
CEO, Co-Founder of Viz
Dr Mansi is a former Neurosurgeon and the CEO of Viz.ai an Applied AI Healthcare company.They recently received FDA clearance for the first ever AI aided triage and notification platform, opening the door to AI in acute emergency healthcare. Chris is a clinician innovator, entrepreneur and optimist focused on increasing healthcare access, building and supporting great teams and improving provider experience. Viz.ai builds clinician facing products that enable and empower doctors, allowing them to provide the best care to patients, everytime, everywhere.
Follow Chris Mansi:
About Viz: Viz is a medical imaging company that helps optimize emergency treatment using deep learning technology.
Daniel Perez
Co-Founder, CEO of Hinge Health
With a long personal history of MSK injuries including several leg surgeries, Dan has long been passionate about improving outcomes for musculoskeletal disorders. Originally from Miami, Dan pursued a PhD in the medical sciences at the University of Oxford (currently paused), founding the Oxbridge Biotech Roundtable and OneStart, a large healthcare accelerator program. As CEO, Dan brings startup technology experience and healthcare expertise to Hinge Health.
Follow Daniel Perez:
About Hinge Health: Hinge Health is a patient-centered digital clinic for treating chronic musculoskeletal conditions.
Maury Blackman
President & CEO of Premise Data
Maury Blackman is CEO of Premise Data. Blackman is a tech executive with more than 25 years of experience leading high growth enterprise software companies. His industry experiences include government, construction, public safety, geospatial information, GPO’s, sharing economy services, and drone software. Blackman joined Premise in 2017; under his leadership the company has seen 661% revenue growth. In November 2020, Premise was named to Deloitte’s Technology Fast 500, a list of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America. Premise is the 35th fastest-growing company in the Silicon Valley region and is 182nd on the overall list. Before joining Premise, Blackman was CEO at Accela, a civic tech company aimed at moving citizen transactions from city hall to online and mobile services. He joined the company in 2000 as the VP of Sales and Marketing and then assumed the role of CEO in 2007. To support strategic initiatives and growth, he raised more than $300M in financing from family offices, private equity, and senior debt. The capital from these raises was deployed to build out an enterprise offering, expand internationally, and execute an M&A strategy that closed 10+ acquisitions in 24 months. Prior to joining Accela, Maury worked for Investools (NASDAQ:IEDU) where he served in several executive positions from 1993 to 2000. At Investools, he first joined as an Account Executive and was later appointed Vice President, Business Development charged with selling data and content to brokerage firms and internet service providers in the nascent dot-com era. In this capacity, he built a dynamic portfolio of accounts that included Charles Schwab, Fidelity, AOL, and Netcom Online Communications. For his accomplishments at Accela, Blackman was recognized by Government Technology as one of its Top 25 Doers, Dreamers, and Drivers in 2015. In 2016, Ernst and Young awarded him the prestigious Northern California’s Entrepreneur of the Year. Maury holds a B.A. in Political Science from the University of Houston and was a commissioned field artillery officer in the United States Army, serving on both active and reserve duty for 10 years. Maury maintains an active lifestyle and is an eleven-time Ironman finisher, including the 2008 and 2013 Ironman World Championship in Kailua-Kona.
Follow Maury Blackman:
About Premise Data: Premise is a data and analytics platform powered by a global network of on-the-ground contributors, data science, and machine learning.
David Goldhill
Co-Founder & CEO of Sesame
David Goldhill is the founder and CEO of Sesame.
Follow David Goldhill:
About Game Show Network, Sesame: Sesame is a healthcare superstore, with over 10,000 medical practices offering affordable prices for care in-person or online.
Jonathan M. Rothberg
Co-Founder, Product Architect & CEO of Butterfly Network
Jonathan Rothberg is Co-Founder, Product Architect & CEO at Butterfly Network.
Follow Jonathan M. Rothberg:
About Butterfly Network: Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Zhen Li
Founder, President & CEO of ADARx Pharmaceuticals
Dr. Li is a co-founder of ADARx and a successful executive with more than two decades of diverse experience in research and development in the pharmaceutical and biotech industries. Prior to ADARx, Dr. Li served as Senior VP at Arrowhead Pharmaceuticals where she led the discovery and non-clinical development of Arrowhead’s delivery platform and multiple product candidates that are now in clinical studies. Previously, Dr. Li was a director at Merck, leading a team dedicated to siRNA development. Dr. Li received her Ph.D. in Chemistry and Chemical Biology from Harvard University, and her B.S. from Peking University.
Follow Zhen Li:
About ADARx Pharmaceuticals: ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
Dwight Crow
Co-Founder and CEO of Whisper
Dwight Crow is a product manager at [Facebook](https://www.crunchbase.com/organization/facebook#/entity), an online social networking service. Previously, he served as the founder of Carsabi.com. He is also the Co-Founder and CEO at Whisper.ai. Crow holds a bachelor’s degree in chemical biology and computer science from the [University of California, Berkeley](https://www.crunchbase.com/organization/university-of-california-berkeley#/entity). He is based in San Francisco, California, United States.
Follow Dwight Crow:
About Meta, Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Shane J Schaffer
Chairman and CEO of Cingulate Therapeutics
Shane J. Schaffer, PharmD is a Co-Founder of Cingulate Therapeutics and has served as the Chairman and CEO since its inception. Dr. Schaffer is an 18-year pharmaceutical industry veteran with experience in pharmaceutical drug development, commercialization and biotech commercial operations. During his career, he has held positions of increasing responsibility at Pfizer, Novartis and Sanofi (including predecessor companies). Dr. Schaffer has broad functional and therapeutic expertise through the development and commercialization of several billion dollar brands including the ADHD Franchise of Ritalin® & Focalin®, Lipitor®, Lyrica®, Eligard®, Arixtra®, Hyalgan® and Avapro®/Avalide®. He has led the strategic brand planning, franchise resource allocation and managed care & reimbursement strategy for numerous products. Dr. Schaffer received his Doctor of Pharmacy degree from the University of Kansas. He served as Chief Fellow and completed a Post-Doctoral Pharmaceutical Industry Fellowship at Rutgers University, College of Pharmacy in conjunction with Warner-Lambert/Parke-Davis, now Pfizer.
Follow Shane J Schaffer:
About Cingulate Therapeutics: Cingulate Therapeutics uses a unique combination of delivery technology and proven medications that creates an unmatched release profile.
David Ronick
Co-Founder and CEO of Minded
David is a co-founder of Minded and Stash, an LP in The Fund, and mentor to entrepreneurs at TechStars, Harvard Business School and Brown University
Follow David Ronick:
About Minded: Minded is a consumer telehealth company that makes getting mental health medication easy and affordable
Mehdi Maghsoodnia
Founder and Chief Executive Officer of 1Health
Mr. Maghsoodnia is currently serving as CEO of 1Health.io and Vitagene. He is also on the board of SpineZone and MedCorder. He previously served as CEO of Rafter, BookRenter.com, SVP of products at CafePress, COO at Actiance and SVP at Intellisync. Mr. Maghsoodnia is a industry fellow at UC Berkeley where he teaches innovation and entrepreneurship. He studies EECS in UCB and Stanford with an emphasis in AI and Machine learning.
Follow Mehdi Maghsoodnia:
About 1Health: 1health’s Testing as a Service (TaaS) Solution empowers precision testing and end-to-end process management in one simple, scalable tool.
JT Garwood
CEO & Co-Founder of bttn.
JT Garwood is CEO & Co-Founder of bttn. bttn. democratizes pricing on the worlds most vital supplies. JT founded bttn. to reduce the cost of healthcare. Prioritizing buyers wallets, lowering capital costs of high quality medical supplies, and price transparency through advanced data insights for healthcare providers across the country. Prior to becoming an entrepreneur, JT had a highly awarded career in sales at Microsoft. JT studied International Business and Chinese at The University of San Diego, and MBA from Whitman School of Management at Syracuse University. JT is an angel investor and early stage advisor to startups in WA & CA
Follow JT Garwood:
About bttn.: bttn. offers subscription-based ordering on direct-from-manufacturer medical supplies.
James C. Katzaroff
CEO, Chairman and Founder of Vivos Inc
A serial entrepreneur who started his first company importing minerals and pewter from Brazil while in high school in southern California, Mr. Katzaroff is constantly searching for outstanding opportunities. Hired straight out of college Mr. Katzaroff was a financial consultant for Wall Street firms Bateman Eichler, Smith Barney and EFHutton. Since 1990, he has been responsible for corporate engineering, senior-level corporate strategy, fostering investment bank relationships, and has served as a senior financial advisor for numerous start-ups and development stage companies. A strong desire to make an unshakable impact in the fight against cancer led Mr. Katzaroff to found AMI in 2006.
Follow James C. Katzaroff:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Kim D. Blickenstaff
President and Chief Executive Officer of Tandem Diabetes Care
Kim joined Tandem in August 2007, bringing more than 30 years of healthcare experience in finance, marketing management, sales and strategic planning. Prior to joining Tandem, he was Chairman, Chief Executive Officer and co-founder of Biosite Incorporated, a medical diagnostic company that was acquired by Inverness Medical Innovations for $1.8 billion in June 2007. Prior to founding Biosite, he held various finance, operations, research management, sales management, strategic planning and marketing positions with Hybritech Incorporated and Baxter Healthcare. Kim has been active in the medical device and diagnostics industry over the last 12 years, serving on the board of directors for innovative, young healthcare companies such as SenoRx and MediVation Incorporated. He holds a Masters of Business Administration from Loyola University Chicago’s Graduate School of Business.
Follow Kim D. Blickenstaff:
About Tandem Diabetes Care: Tandem Diabetes Care develops medical devices for the treatment of diabetes offering diabetic insulin pumps for adults and children.
Wei-Wu He
Founder and CEO of Origene Technologies
Wei-Wu He is a biotech executive dedicated to the commercialization of innovative life sciences technologies for the healthcare market.He is currently Chairman and CEO of OriGene Technologies, Inc. He is also the founder and General Partner of Emerging Technology Partners, LLC (ETP), a venture firm dedicated to incubating innovative life sciences companies. He is also a Venture Partner of IDG/Accel Partners, a $4 Billion venture fund designed to fund innovative companies in China.He started his biotech career as a scientist at the inception of Human Genome Sciences, Inc.He has been involved in the funding and founding over 20 biotech companies throughout his career and has served on many biotech company boards. Most recently He was named the Executive Chairman of Casi Pharmaceuticals, a biotech company dedicated to the development of innovative cancer treatments both in China and the US.He has conducted cancer research at Mayo Clinic and at Massachusetts General Hospital as a research fellow. He has been awarded over 30 United States patents and has more than 25 original research publications.He received a Bachelor’s degree in Biochemistry from Nanjing University, P. R. China, an M.B.A. from Wharton School of the University of Pennsylvania, and a Ph.D. in Molecular Biology from Baylor College of Medicine.
Follow Wei-Wu He:
About Emerging Technology Partners, Origene Technologies: OriGene Technologies is a research tool company that provides a commercial collection of full-length human cDNAs.
Paul Molloy
President & CEO of ClearFlow
Paul has over twenty years experience of operations, executive management and Board work at public, private and VC funded medical device companies. Two IPO’s at previous companies, particularly as President & Managing Director orchestrating LMA’s successful 2005 SGX listing at a market capitalization of >$300m. LMA was recently acquired by Teleflex in a process that he brokered. Paul was a practicing CRNA until he joined Datascope Corp in NJ in 1989, obtaining his MBA from the University of Chicago’s Booth School of Business and rising through executive positions with leading medical device firms to CEO level in successive start ups, most recently completing the sale of VasoNova to Teleflex Inc. He has extensive global industry connections and has traveled, lived and worked in Asia, Europe and the USA, including substantial experience setting up and managing operations in Australia, Germany, Switzerland, Singapore, China, Japan, India and Latin America as well as serving on the Board of those local subsidiaries.
Follow Paul Molloy:
About ClearFlow: ClearFlow is a medical device company developing technologies to solve clinical problems associated with obstructed catheters.
Clay Larsen
President and CEO, Co-Founder of Vesselon
Mr. Larsen co-founded Vesselon in 2012 and brings over thirty years of executive management, marketing, sales, clinical innovation and engineering/project management in the healthcare industry. Mr. Larsen was a senior executive with FUJIFILM Medical Systems, where he was largely responsible for building the company’s first healthcare software division from the ground up. Mr. Larsen recruited the original senior architects and was instrumental in the development, marketing, commercial release and field support of Fuji’s Synapse® Picture Archive and Communication System (PACS). In a move to Silicon Valley in 1988, Mr. Larsen served in several senior roles at Acuson Corporation culminating as Vice President of New Market Development. Acuson was one of the leading ultrasound technology companies that was later acquired by Siemens. Early in his career he specialized in Sales and Marketing Management of Ultrasound and Nuclear Medicine for Picker International. Mr. Larsen holds a B.S. in Molecular Biophysics and Biochemistry from Yale University.
Follow Clay Larsen:
About Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Philip Fung
Founder / CEO of Kit.com
Founder/CEO @Kit.com, Engineer #15 @Facebook
Follow Philip Fung:
About Kit.com: Kit.com is a home medical exams, delivered. Kit makes health testing simpler, easier and more reliable for your patients.
Drew Perkins
Co-Founder and CEO of Mojo Vision
Follow Drew Perkins:
About Mojo Vision: Mojo Vision is developing Mojo Lens, the world’s first AR smart contact lens with a built-in display that delivers Invisible Computing
John Haley
CEO of Willis Towers Watson
Follow John Haley:
About Willis Towers Watson: Willis Towers Watson is a global advisory and solutions company that helps clients around the world turn risk into a path for growth.
Jeff Albers
Chief Executive Officer of Blueprint Medicines
Jeff Albers is the chief executive officer of [Blueprint Medicines](https://www.crunchbase.com/organization/blueprint-medicines), a company engaged in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets. He was previously the president of Algeta. Prior to Algeta, he served at Genzyme, where he spent seven years in senior commercial and corporate development positions. Before joining Genzyme, he spent five years as an Attorney at the law firm Mintz Levin Cohn Ferris Glovsky & Popeo. He also has prior experience as a sales representative for Pfizer. Albers holds a bachelor’s degree in marketing from Indiana University and an MBA from Georgetown University.
Follow Jeff Albers:
About Blueprint Medicines: Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
Ernie Sadau
President, CEO of CHRISTUS Health
Ernie Sadau is responsible for day-to-day operations of CHRISTUS Health and lends extensive expertise in developing programs to improve quality and clinical integration and preparing the organization to capitalize on the opportunities of the future. Ernie joined CHRISTUS as Senior Vice President of Patient and Resident Care Operations in 2006. His title was changed to Senior Vice President and Chief Operating Officer in 2008 as he expanded his role and oversight within the organization. Ernie also served as the Chief Diversity and Inclusion Officer for CHRISTUS Health, developing the strategic initiatives and processes to ensure that CHRISTUS is living out its commitment to valuing differences and strengthening the ministry’s culture of inclusion. Before joining CHRISTUS, Ernie served in many roles at Adventist Health System from 1983-2006, holding various executive positions in the organization’s many hospitals and systems, including Chief Financial Officer, Administrator, and President and CEO of Adventist Health System/Midwest in Hinsdale, Ill., which includes five hospitals, over 60 physician practices, surgery and imaging centers and several home care agencies. During his tenure with Adventist, Ernie led successful hospital acquisitions and joint ventures; implemented thriving physician recruiting, community relations and employee development programs and developed many necessary medical services in the communities he served, including opening the only freestanding Emergency Room in Illinois and a Level III Neonatal Intensive Care Unit. Ernie holds a master’s degree in Hospital Administration from Southwest Texas State University in San Marcos, Texas. He received his undergraduate degree in Business Administration from the University of North Texas. Ernie is a Fellow of the American College of Health Care Executives, and was named an Up & Comer by Modern Healthcare magazine in 2000, an award that honors rising young stars in the health care management field.
Follow Ernie Sadau:
About CHRISTUS Health: Christus Health is an international Catholic, faith-based, not-for-profit health system
Josh Guttman
Co-Founder and CEO of Small Door
Prior to co-founding Small Door, Josh led a successful with diverse experiences that included management roles at a number of significant technology companies and roles in both investment banking and venture capital. From 2013 – 2017, Josh worked as a Partner on the early stage investing team at Softbank Capital, a $500 million venture capital arm of Softbank Corporation. While at Softbank, Josh led early stage investments in software businesses with a focus on healthcare and real estate. Before Softbank, Josh served as Senior Vice President at Outbrain, the leading content marketing platform, where he oversaw growth of the business from 50 to 250 worldwide employees in a three-year timespan. Previously, in 2007, Josh joined the early team at Sphere and helped grow the business to their eventual acquisition by Aol in 2008. Post-acquisition, Josh led the business as CEO for two years, ultimately initiating its divestiture and sale to Outbrain in early 2011. Josh began his career in investment banking at Robertson Stephens & Co in San Francisco where he participated on more than $400 million of private equity and debt financings from 1998 – 2002. Josh earned an AB from Duke University and an MBA from Columbia University. He lives in Brooklyn with his wife, two daughters, and boxer, Morrison.
Follow Josh Guttman:
About Small Door: Small Door provides veterinary services that are elevated, customer-centric, and hospitality-infused.
Fei Li
Chief Executive Officer & Chairwoman of Hycor Biomedical LLC
Fei Li first joined Hycor in 2016 as President and Chairwoman of the Board. In September 2017, she became President and CEO of Hycor. Dr. Li has over 20 years’ experience in the fields of in vitro diagnostics (IVD), medical devices and Clinical Medicine. Over her distinguished career, Dr. Li has consistently demonstrated her ability to deliver results as she has led teams that improved product design, realized operational efficiency and recognized investment opportunities in the domestic and international healthcare sector. Dr. Li’s strengths include her extensive experience in building and empowering a team to manage through organizational growth to improve processes, decrease costs and accelerate business performance. Dr. Li also has extensive investment experience in the healthcare industry. She has successfully executed cross-border transactions and has been effective in managing pre- and post-investment activities between stakeholders and investment targets. Dr. Li has had the distinction of serving in multiple strategic roles including Chief Operating Officer for QuantumTech Medical Devices during 2016-2017, Chief Operating Office for Beyond Diagnostics Inc. between 2008 – 2011, Head of Business Development for Siemens Healthcare China from 2007 – 2008 and Director of Product Validation for Diagnostic Products Corporation from 2006 – 2007. Dr. Li holds a medical degree from San Yat-Sen University in Guangdong, China. In addition, she received a Ph.D. degree in Biomedical Sciences from the University of California, Riverside and a Master of Business Administration (M.B.A.) from the University of Redlands.
Follow Fei Li:
About Hycor Biomedical LLC: Hycor Biomedical is a medical device company that provides vitro diagnostics products.
Jeff Dachis
Founder, Chairman & CEO of One Drop
After Jeff Dachis was diagnosed with type 1 diabetes, he set out to create a data-driven digital platform that would disrupt the reactive healthcare model. In 2015, One Drop was born. The precision health company combines continuous diagnostics, predictive analytics and machine learning in an award-winning digital solution to deliver cost-saving outcomes for people worldwide living with diabetes and other chronic conditions. Next, One Drop plans to enter the market with a daily disposable, minimally invasive continuous health sensor in development designed to provide greater flexibility and insights for people living with diabetes compared to fingersticks alone. The availability of this proprietary sensor is subject to receipt of clearance or approval from the U.S. FDA. Before One Drop, Dachis co-founded Razorfish (NASDAQ: RAZF) and led its $55MM IPO, then founded the Dachis Group (acquired by Sprinklr). Dachis has appeared on Crain’s 40 Under 40 list and was named EY Entrepreneur of the Year. An internet pioneer, having helped create the first banner ad and web animation, Dachis now channels his passion for data, technology, and design at One Drop, building data-driven products that empower people to take charge of their health.
Follow Jeff Dachis:
About One Drop: One Drop is a diabetes management platform that helps people navigate diabetes together.
Michael Boerner
CEO of Engage Media & Technology
Michael Boerner is a serial entrepreneur with more than 24 years of experience founding and leading media and technology companies. Before founding Transilio in 2012, he launched Unity Media Group, a provider of enterprise platforms and services that allow companies in healthcare delivery and other sectors to create, deliver and manage digital video content targeting customers and other key audiences. He also founded Unity Medical, Inc., a provider of digital educational tools for enhancing patient experiences. The companies’ clients included Johnson & Johnson, DePuy Synthes Companies, Covidien, St. Luke’s Health System, K12, Blue Cross Blue Shield, Duke Medical Center and the Ken Blanchard Companies. Mr. Boerner also founded Mission Media, a 501(c) 3 values-based media-syndication company. In his previous positions, he was responsible for raising more than $20 million in capital. He also developed several business and video-based methodologies and technologies to allow personalized customer engagement. In addition to being a national award-winning film and video producer, Mr. Boerner is a TEDMED 2013 Frontline Scholar. He serves on the Idaho Governor’s Coordinating Council for Families and Children and on the board of directors for the National Institute of Marriage. Mr. Boerner has appeared nationally on CNN, Fox News, ABC Radio Network News, as well as in numerous press articles.
Follow Michael Boerner:
About Dental Innovations, Inc., Engage Media & Technology, Engage Technologies Group: Engage Media & Technology focuses on developing mobile video technologies in multiple marketplace verticals.
Cheng Liu
Founder, CEO of Eureka Therapeutics
Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health. Dr. Liu received his B.S. in Cell Biology and Genetics from Beijing University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.
Follow Cheng Liu:
About Eureka Therapeutics: Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Maria Artunduaga
Founder and CEO of Respira Labs
Follow Maria Artunduaga:
About Respira Labs: Respira Labs is building an AI-powered sensor platform to track, predict, and prevent chronic lung disease.
Eric Hunter
CEO of Pneuma Respiratory
Serves as the Company’s Chief Executive Officer. Mr. Hunter is author or co- author on over 130 patents. He has extensive experience in the founding and managing a range of businesses in the high technology, manufacturing and medical device industries. Two of these companies, Cree Inc. and Charles & Colvard LLC, are publicly traded on Nasdaq. Mr. Hunter also co-founded a medical device company, Quill Medical, which was sold to Angiotech Pharmaceuticals, Inc. for $200 million in 2005 and an eye care company, Corinthian Ophthalmic, Inc., that was sold to Eyenovia, Inc. in 2014.
Follow Eric Hunter:
About Pneuma Respiratory: Pneuma Respiratory is a pharmaceutical company that creates digital solutions for respiratory drug delivery.
Ashok Subramanian
Founder/CEO of Centivo
Ashok is a successful founder and CEO with significant expertise in HR and healthcare technology businesses. He is co-founder and CEO of Liazon, the nation’s leading private benefits exchange for active employees. In 2013, Liazon was acquired by Towers Watson. Ashok continues to serve as CEO of Liazon, as well as the Head of Willis Towers Watson’s Group Exchange business. Prior to Liazon, he worked as a strategy consultant at McKinsey & Company. Ashok is often sought out for his expert commentary on private and public exchanges, their role in the new healthcare landscape and their effect on businesses. He received his undergraduate degree from Princeton University, a Masters degree from Stanford University, and an MBA from the Stanford Graduate School of Business.
Follow Ashok Subramanian:
About Centivo: Centivo offers a digital health plan aimed at self-funded employers looking to provide employees with quality care they can afford.
Sami Inkinen
CEO & Founder of Virta Health
Sami Inkinen is the Chief Executive Officer and Co-Founder of Virta Health, a specialty medical clinic that reverses type 2 diabetes safely and sustainably, without the risks, costs, or side effects of medications or surgery. Previously, Mr. Inkinen was the co-founder of the leading online real estate marketplace Trulia, serving as its COO and president and board member until its IPO and eventual sale to Zillow Group. He also worked on Microsoft’s strategy team for MS Office, and as a consultant for McKinsey & Company within the software, telecommunications, and government sectors. A physicist by training, Mr. Inkinen started his career as a radiochemist at a nuclear power plant and holds a Master of Science in engineering physics from the Helsinki University of Technology. He also earned a Master of Business Administration from Stanford University. He thinks his greatest luxury today is a small vegetable garden at his San Francisco Bay area home.
Follow Sami Inkinen:
About Virta Health: Virta delivers a clinically-proven treatment to reverse type 2 diabetes and other chronic metabolic diseases.
Omri Shafran
CEO of Texas Medical Technology
Follow Omri Shafran:
About SureSpot, Texas Medical Technology: Texas Medical Technology specializes in the sale and distribution of wide range of medical equipment.
Marc Korczykowski
CEO and Co-Founder of Hura Imaging
Marc Korczykowski is Hura Imaging’s Co-Founder and CEO.
Follow Marc Korczykowski:
About Hura Imaging: Hura Imaging develops and commercializes novel CT technology that decreases radiation dose significantly in patient management.
Harry Ritter
Founder and CEO of Alma
Harry Ritter is the Founder of Alma Health.
Follow Harry Ritter:
About Alma: Alma is a membership-based network for mental health care providers.
Erica Chidi
Co-Founder & CEO of LOOM
Erica Chidi is a Co-Founder and Chief Executive Officer at LOOM.
Follow Erica Chidi:
About LOOM: LOOM is a platform helping women optimize their sexual and reproductive wellbeing.
Gino Volpacchio
Chairman and CEO of PetVet Care Centers
Gino has extensive leadership experience in the pet care industry, and founded PetVet Care Centers in 2012. He is the consummate expert at putting together hospital acquisitions that provide maximum benefits to both sellers and buyers—every time.
Follow Gino Volpacchio:
About PetVet Care Centers: PetVet Care Centers is an operator of specialty and general practice animal hospitals in the United States.
Austin Pittman
CEO of UnitedHealthcare Community & State
Austin Pittman is the President at Powderhorn Ventures, LLC.
Follow Austin Pittman:
About Blue Norther Hard Seltzer, Gauge Capital, Optum, Powderhorn Ventures, UnitedHealthcare Community & State: UnitedHealthcare Community & State is the premier provider in the United States of high quality, personalized public sector health care.
Doug Hudson
CEO and Co-Founder of Tend
Doug Hudson is the founder and Chief Executive Officer of Tend. Born out of the need for systemic change across the dental industry, Doug’s vision is for Tend to set a new standard for oral health, starting at the dentist. As CEO, Doug applies his past experience spearheading numerous high-growth healthcare ventures to bring a hospitality mindset to the dental industry. Previously, Doug was the founding CEO of SmileDirectClub, a leading direct-to-consumer orthodontics company. Prior to this, he founded and led several consumer health companies including DiabetesCareClub and CPAPCareClub, Inc. and HearingPlanet, Inc., the latter of which became the largest online hearing aid distributor in the U.S. during his tenure.
Follow Doug Hudson:
About Tend: Tend is a technology-driven dental startup that provides hassle-free, personalized, and straightforward dental services.
Samir Housri
CEO & Co-Founder of The Mednet
Samir Housri the CEO & Co-founder of theMednet. Under his leadership theMednet has become the largest online physician network in Oncology and one of the fastest growing in medicine. Samir’s career spans nearly 20 years in digital media that spans operations, technology and strategy. Most recently he was part of the investment team at Rho Ventures where he sat on multiple boards and deployed over $50M in capital. Prior to that, he was part of EMI Music’s global business development team where he drove the launch of EMI’s ad-supported video platform. He was also involved in all aspects of digital content licensing and distribution, including contract negotiations, technical implementation and monetization. Prior to EMI, Samir served as a management consultant with Bain & Company where he worked on strategy for technology and media clients. He started his career as a software engineer for Major League Baseball and was a key member of the team that built MLB.com.
Follow Samir Housri:
About The Mednet: The Mednet is a physician-only community for expert answers to real world clinical questions in oncology.
Flaviu Simihaian
Co-Founder & CEO of Troy Medicare
Flaviu Simihaian is the co-founder and CEO of Troy Medicare, the first pharmacy-powered, AI-driven Medicare Advantage plan. Flaviu also co-founded and is the chairman of Amplicare (previously iMedicare), a web-based SaaS platform that 7,000 pharmacies use to manage and grow their business.
Follow Flaviu Simihaian:
About TechAngels, Troy Medicare: Troy Medicare is arming independent pharmacies with a health plan and platform tailored to their most vulnerable patients.
Jason Krantz
CEO of Definitive Healthcare
Jason Krantz is Founder & CEO at Definitive Healthcare.
Follow Jason Krantz:
About Definitive Healthcare, Energy Acuity: Definitive Healthcare aims to transform data, analytics and expertise into healthcare commercial intelligence.
Stephen Chen
Founder & CEO of Scanwell Health
Co-Founder and President at Learn To Be Foundation. Founder at Petnostics.
Follow Stephen Chen:
About Learn To Be Foundation, Petnostics, Scanwell Health: Scanwell Health is an FDA-cleared urine testing application.
Fabien Beckers
Founder & CEO of Arterys
Fabien Beckers is the CEO and co-founder of Arterys, a cloud/deep learning startup that is disrupting the medical imaging space and building image-based precision medicine tools. Fabien has led the growth of the company from four co-founders to a team of 34 today. Under his leadership, the company has become a pioneer in cloud-based medical imaging software, offering the first FDA-cleared end-to-end cloud infrastructure for medical imaging. They key advantages of the platform being automatic aggregation of real-world data and ability to scale and distribute the processing of increasingly large, complex datasets. Fabien’s vision for the company is to accelerate data-driven medicine by building precision medicine tools based on the consistent quantification of medical image features in combination with molecular, genomics and patient history data. Fabien holds a PhD in Quantum Physics from the University of Cambridge and a masters of business from Stanford University.
Follow Fabien Beckers:
About Arterys: Arterys is a medical imaging platform to deliver clinical AI products over the internet.
Clinton Phillips
Founder of 2nd.MD and Medici & CEO of Medici
Clinton Phillips is the founder and CEO of Medici and launched the company in early 2017 with a vision to create technology that would revolutionize the way doctors provide care to their patients and to build a next generation virtual health+care system that gives patients access to a personal medical team made up of exceptional doctors, nurses, and specialists right from their phone.
As a serial-entrepreneur Clinton previously founded 2nd.MD in response to frustrations he had experienced when seeking medical care for his daughter, Gabi, who had suffered a stroke shortly after birth. 2nd.MD has since helped thousands of people in over 45 countries gain access to high-quality second opinions with outcomes that has saved lives and lowered healthcare and recovery costs for patients, providers and carriers. Clint sold 2nd.MD to Accolade in 2021.
Before this, Clinton served as a consultant to The Vitality Group working to lower healthcare spending through employee education and engagement programs. Clinton is also a certified Chiropractor and founded the successful Colorado-based Aspen Back & Body, a non-surgical rehabilitation clinic for people with back problems. Originally from South Africa, Clinton and his family now reside in Austin, Texas.
Follow Clinton Phillips:
About 2nd.MD, Medici: Medici is a mobile technology platform that provides text, video, and voice chats between patients and doctors.
Amit Vohra
Co-Founder, President & CEO of Promaxo
Promaxo is led by Dr. Amit Vohra who is a serial entrepreneur, business strategist and advisor to several healthcare and technology startups. Amit is a Partner in Advanced Biopharma Consulting, a management consultancy offering strategic business development and commercialization services in the life sciences space. He also serves as an advisor to Cricking, MedDx and HealthyX and a strategy consultant to Precision Biopsy and Weinberg Medical Physics. Prior to Promaxo, Amit was the CEO/President of Convergent Life Sciences wherein he took a MRI-US fusion product, for targeted laser ablation of soft tissue cancer, through FDA clearance within 18 months of Company formation. Previously, as VP of Strategy and Operations at Eigen, he led the development and successful commercialization of two class II medical devices in the prostate biopsy space. In 2009, Amit co-founded Navya Biomedical Technologies, a biotechnology company using proprietary polyhydroxy fullerenes (PHF) for non-invasive imaging and destruction of solid tumors. Amit has a Doctorate in Mechanical Engineering from University of Florida, and an Executive MBA (Fuqua Scholar) from Duke University’s Fuqua School of Business.
Follow Amit Vohra:
About 8chili, Neuro42, Promaxo, TriOcula Technologies: Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician’s office.
Teddy Scott
CEO and Founder of PharmaCann
Teddy Scott is the Founder and CEO of PharmaCann.
Follow Teddy Scott:
About PharmaCann: PharmaCann is a vertically-integrated and unified medical cannabis company changing the way people view cannabis.
Paul Grand
CEO of MedTech Innovator
Follow Paul Grand:
About MedTech Innovator: MedTech Innovator is the largest lifescience accelerator in the world for medical device, digital health, and diagnostic companies
David Osborne
CEO of Virgin Pulse
David Osborne is a seasoned business technology leader with more than 20 years’ experience in global sales, operations, transformation planning, execution and M&A. He brings deep experience in operations, strategic growth, and executive management and a proven record of helping organizations successfully integrate, operationalize, and scale their businesses. As President and COO of Virgin Pulse, Dave is responsible for streamlining, optimizing, and scaling Virgin Pulse as the company continues its aggressive growth strategy and solidifies its position as the largest workplace wellbeing company in the world. A former NCAA Division I golfer, Dave has seen and experienced, firsthand, that investing in building healthy habits and skills pays significant dividends in driving performance and long term success, personally and professionally. He is a firm believer in Virgin Pulse’s ability to help organizations drive business outcomes that matter by empowering and supporting employees across all aspects of their personal and professional wellbeing. Prior to joining Virgin Pulse, Osborne was the COO at Drillinginfo, which provides data software to the oil and gas industry, where he was instrumental in developing the company’s operating model and product growth strategy. Prior to Drillinginfo, Osborne served as Managing Director of Vista Consulting Group, where he helped Vista portfolio companies develop strategies to drive growth and improve operations while accelerating business outcomes. During his tenure he helped acquire, transform, and integrate over 30 companies. Dave holds an an MBA from the University of Georgia, Terry College of Business and an undergraduate degree in Finance.
Follow David Osborne:
About CaseWare, Virgin Pulse: Virgin Pulse, part of the famed Virgin Group, is passionate about inspiring and engaging employees to live better every day.
Oliver Kharraz
CEO & Co-Founder of Zocdoc
Oliver Kharraz, MD, is CEO and founder of Zocdoc. Oliver is the most recent doctor in a 300-year family tradition. Over the course of his wide-ranging career, Oliver has accrued comprehensive experience effecting change and building efficiency in large scale healthcare organizations using information technology. Prior to Zocdoc, Oliver was an Associate Principal at the global management consulting firm McKinsey & Company. During his seven-year tenure at McKinsey & Co., Oliver developed and implemented new patient utilization models for the national health services of a number of governments and major hospital chains. In 1994, Oliver built and sold his first business – a forerunner of early internet software. He later became a resident doctor at the clinic of Ludwig Maximilian University in Munich, where he earned an MD and a Doctorate in Neuroscience. Oliver also has a Masters Degree in Philosophy from the Jesuit College of Philosophy in Munich. He is also a member of the Council on Foreign Relations. Born in Germany, Oliver immigrated to the U.S. during his work for McKinsey & Co. He currently resides in Brooklyn, NY, with his wife and their twin daughters.
Follow Oliver Kharraz:
About Creative Destruction Lab (CDL), Zocdoc: Zocdoc is a digital marketplace company that connects healthcare patients and doctors.
Deborah Kilpatrick
Chief Executive Officer of Evidation Health
Deborah Kilpatrick is the Chief Executive Officer of Evidation Health.Prior to this role, she served as the Chief Commercial Officer of genomic diagnostics company CardioDx. Earlier in her career, Deborah held multiple leadership roles at Guidant Corporation, including Research Fellow, Director of R&D, and Director of New Ventures in the Vascular Intervention Division. She serves on the Georgia Tech Advisory Board and is a Fellow of the American Institute of Medical and Biological Engineering. Deborah is a co-founder of the MedtechVision Conference, now held annually in Silicon Valley. She holds BS, MS and PhD degrees in mechanical engineering with a bioengineering focus from Georgia Tech.
Follow Deborah Kilpatrick:
About Evidation Health, MedTech Women: We enable and empower everyone to participate in better health outcomes.
Larry Merlo
CEO of CVSHealth
Larry Merlo is President and Chief Executive Officer of CVS Health, a pharmacy innovation company that is at the forefront of a changing health care environment. The company, with net annual revenues of $139 billion, touches more than 100 million people each year through its unique combination of assets, including 7,900 retail pharmacies, more than 1,000 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, a comprehensive provider of pharmacy services to long term care facilities, and expanding specialty pharmacy services. Under Merlo’s leadership, the company is transforming health care by delivering breakthrough products and services that enable people, businesses and communities to manage health in more affordable, effective ways. As part of this deep commitment to public health, in 2014 the company announced the landmark decision to be the first major retail pharmacy to eliminate tobacco sales in all of its stores. To reflect this broader health care commitment, the company subsequently changed its corporate name to CVS Health. Merlo, a pharmacist by education, joined CVS/pharmacy in 1990 through the company’s acquisition of Peoples Drug. Prior to assuming the role of President and CEO in 2011, Merlo held positions of increasing responsibility, most recently President of CVS/pharmacy. Under his leadership, the company completed some of the most successful acquisitions in the history of retail pharmacy and delivered significant organic growth in major markets across the country. Merlo currently serves on the Board of the National Association of Chain Drug Stores (NACDS) and the University of Pittsburgh’s Board of Trustees. He is also a member of the Business Roundtable. He is a graduate of the University of Pittsburgh School of Pharmacy.
Follow Larry Merlo:
About CVSHealth: CVS Health provides an integrated healthcare services offering for its members.
Timothy Warbington
President and CEO of Creative Medical Technology Holdings
Follow Timothy Warbington:
About Creative Medical Technology Holdings: Creative Medical Technology Holdings is a biotechnology company focused on Immunology, Urology, Neurology, and Orthopedics.
Walter De Brouwer
Co-Founder & CEO of doc.ai
CSO & founder at doc.ai, Chief Executive Officer at XY.ai, Chair at IEEE, Stanford MD Admissions MMI Rater at Stanford University & Investment Banker at Lazard Asset Management.
Follow Walter De Brouwer:
About doc.ai, Lazard Asset Management, Stanford University, Stanford University School of Medicine, XY.ai Inc., Yale School of Management (SOM): doc.ai is a digital health company designed for a new generation of medical research.
